Correlation Between Dyadic International and TC BioPharm
Can any of the company-specific risk be diversified away by investing in both Dyadic International and TC BioPharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyadic International and TC BioPharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dyadic International and TC BioPharm Holdings, you can compare the effects of market volatilities on Dyadic International and TC BioPharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyadic International with a short position of TC BioPharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyadic International and TC BioPharm.
Diversification Opportunities for Dyadic International and TC BioPharm
-0.45 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Dyadic and TCBP is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Dyadic International and TC BioPharm Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TC BioPharm Holdings and Dyadic International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyadic International are associated (or correlated) with TC BioPharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TC BioPharm Holdings has no effect on the direction of Dyadic International i.e., Dyadic International and TC BioPharm go up and down completely randomly.
Pair Corralation between Dyadic International and TC BioPharm
Given the investment horizon of 90 days Dyadic International is expected to generate 0.42 times more return on investment than TC BioPharm. However, Dyadic International is 2.39 times less risky than TC BioPharm. It trades about 0.02 of its potential returns per unit of risk. TC BioPharm Holdings is currently generating about -0.08 per unit of risk. If you would invest 155.00 in Dyadic International on September 12, 2024 and sell it today you would earn a total of 4.00 from holding Dyadic International or generate 2.58% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dyadic International vs. TC BioPharm Holdings
Performance |
| Timeline |
| Dyadic International |
| TC BioPharm Holdings |
Dyadic International and TC BioPharm Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dyadic International and TC BioPharm
The main advantage of trading using opposite Dyadic International and TC BioPharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyadic International position performs unexpectedly, TC BioPharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TC BioPharm will offset losses from the drop in TC BioPharm's long position.| Dyadic International vs. Werewolf Therapeutics | Dyadic International vs. Edgewise Therapeutics | Dyadic International vs. Celcuity LLC | Dyadic International vs. C4 Therapeutics |
| TC BioPharm vs. ZyVersa Therapeutics | TC BioPharm vs. Palisade Bio | TC BioPharm vs. Unicycive Therapeutics | TC BioPharm vs. Immix Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |